Fresenius Medical Care AG (NYSE:FMS)
$ 21.3 -0.03 (-0.14%) Market Cap: 12.50 Bil Enterprise Value: 24.30 Bil PE Ratio: 17.64 PB Ratio: 0.86 GF Score: 78/100

Fresenius Medical Care AG & Co KGaA Annual Shareholders Meeting Transcript

May 16, 2019 / 08:00AM GMT
Release Date Price: $39.69 (-0.30%)
Robert Maurice Powell
Fresenius Medical Care AG & Co. KGaA - Chairman of the Management Board & CEO of Fresenius Medical Care Mgmt AG

Dear shareholders, it is my great pleasure to welcome you to the Annual General Meeting of Fresenius Medical Care. Our vision is to create a future worth living for our patients worldwide every day. This vision is what drives us forward.

Fresenius Medical Care is the world's leading provider of dialysis products and services. In 2018, we treated more than 330,000 patients, up 4% on 2017. We perform one dialysis treatment every 0.6 second, which means that roughly 80 people have been treated since I started speaking. We provided approximately 50 million treatments in 2018 benefiting patients in more than 3,900 dialysis clinics in approximately 50 countries around the world. This is approximately 5% more clinics than in 2017. More patients, more treatments and more clinics.

A growing number of people around the world can enjoy a better quality of life, thanks to our products and services. To fulfill our vision, we need to be able to provide

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot